iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
– Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of Phase 2 […]
iTeos Therapeutics Announces $120 Million Registered Direct Offering
– Led by existing investors RA Capital Management and Boxer Capital– Purchase price of $17.50 represents a premium of approximately […]
Aqua Metals Joins $4.99 Million DOE Grant Project to Pioneer Domestic Critical Mineral Supply Chain
RENO, Nev., May 10, 2024 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium-ion battery recycling […]
Telos Corporation Announces First Quarter Results Above Guidance: Reports $29.6 Million of Revenue, 37.0% GAAP Gross Margin, and 42.2% Cash Gross Margin
Reports First Quarter Results Above High End of Guidance Range on Key Financial Metrics Delivered $29.6 Million of Revenue, Reflecting […]
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky
Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif., May 10, […]
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
MORRISVILLE, N.C., May 10, 2024 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data related to […]
Mobile-health Network Solutions Expands Services to Malaysia
SINGAPORE, May 10, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth […]
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
— Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial […]
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases
The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features […]
Smart for Life to Attend Vitafoods Europe 2024: Positioned to Identify Strategic Partnerships and Potential Acquisitions
MIAMI, May 10, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a […]
